Get started
Author

Joana F. B. P. Neves

Proceedings of the 3rd IPLeiria’s International Health Congress: Leiria, Portugal. 6-7 May 2016
2016 · Catarina Cardoso Tomás, Emanuel Oliveira, et al. · BMC Health Services Research · 535
PDF
Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance
2021 · Diana Zatreanu, Helen M. R. Robinson, et al. · Nature Communications · 397
PDF
POLQ seals post-replicative ssDNA gaps to maintain genome stability in BRCA-deficient cancer cells
2022 · Ondrej Belan, Marie Sebald, et al. · Molecular Cell · 138
PDF
Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies
2023 · Joana Jorge, Joana Neves, et al. · International Journal of Molecular Sciences · 33
PDF
Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types
2024 · Patrick G. Pilié, Virginia Giuliani, et al. · Clinical Cancer Research · 21
PDF
The attractiveness of Portugal as a tourist destination, by mature domestic travellers
2011 · Joana M.O. Neves · World Review of Entrepreneurship Management and Sustainable Development · 7
Abstract P056: Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance
2021 · Diana A. Zatreanu, Helen M. R. Robinson, et al. · Molecular Cancer Therapeutics · 4
The Pharmacologic Profile of ART6043, a First-in-Class Clinical DNA Polymerase Theta Polymerase Domain Inhibitor Potentiating PARP Inhibitor Efficacy
2026 · Helen M.R. Robinson, Vera Grinkevich, et al. · Clinical Cancer Research · 2
SHLD2 loss is a synthetic vulnerability to Polθ inhibition combined with radiotherapy
2026 · Gonzalo Rodriguez-Berriguete, Purusotha Thambiayah, et al. · Science Advances · 2
PDF
Abstract 2905: Combination of the ATR inhibitor, ART0380, with irinotecan for treating ATM-negative tumors
2025 · Helen M. Robinson, Desiree Piscitello, et al. · Cancer Research · 2
Participação da comunidade, ensino de História e cultura histórica
2013 · Joana Neves · Fóruns Contemporâneos de Ensino de História no Brasil on-line · 2
The Impact of Gamification on Consumer Engagement with Brands: Empirical Evidence
2024 · Joana Neves, Margarida Oliveira, et al. · Sylwan · 1
O serviço de ensino vocacional de São Paulo e a História Local
2013 · Joana Neves · Fóruns Contemporâneos de Ensino de História no Brasil on-line · 1
O ensino público vocacional em São Paulo: renovação educacional como desafio político - 1961-1970
2011 · Joana Neves · Digital Library of Theses and Dissertations (Universidade de São Paulo) · 1
Turismo e cultura: contradiçoes ou convergências?
2008 · Joana Neves · Arkeos: perspectivas em diálogo · 1
O estudos das motivações turísticas dos seniores das universidades da terceira idade através de uma abordagem funcionalista
2006 · Joana Neves, Manuela Sarmento · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · 1
PDF
Data from The Pharmacologic Profile of ART6043, a First-in-Class Clinical DNA Polymerase Theta Polymerase Domain Inhibitor Potentiating PARP Inhibitor Efficacy
2026 · Helen M.R. Robinson, Vera Grinkevich, et al.
Supplementary Data1 from The Pharmacologic Profile of ART6043, a First-in-Class Clinical DNA Polymerase Theta Polymerase Domain Inhibitor Potentiating PARP Inhibitor Efficacy
2026 · Helen M.R. Robinson, Vera Grinkevich, et al.
Abstract 1738: Alnodesertib (ART0380) in combination with irinotecan is highly efficacious in preclinical models of ATM null pancreatic cancer
2026 · Helen M. Robinson, Elias Elinati, et al. · Cancer Research
2821 SHLD2-deficient tumours display high sensitivity to DNA polymerase-theta (Polθ) inhibition combined with radiotherapy
2025 · Gonzalo Rodriguez-Berriguete, Marco Ranzani, et al. · Radiotherapy and Oncology
Data from Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types
2024 · Patrick G. Pilié, Virginia Giuliani, et al.
Supplementary Table S1 from Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types
2024 · Patrick G. Pilié, Virginia Giuliani, et al.
Supplementary S1-S8 from Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types
2024 · Patrick G. Pilié, Virginia Giuliani, et al.
Nailfold videocapillaroscopy findings in COVID-19: a new mimicker of the scleroderma pattern?
2024 · Margarida Correia, Paulo Pereira, et al. · Rheumatology
P581 Transmural remission improves clinical outcomes up to 5 years in patients with Crohn’s Disease
2022 · J Pedro, I Botto, et al. · Journal of Crohn s and Colitis
PDF
Works count: 38
Citation count: 1,148
H-index: 6
I10-index: 5
Year
Topic
Type